Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy

DOI: 10.1177/2050640619841254

Keywords: Hepatitis C, direct antiviral therapy, hepatocellular carcinoma, ombitasvir/paritaprevir/r+dasabuvir+ribavirin, liver cirrhosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text